JPRN-UMIN000023897已完成2 期
Prospective study of evaluating the efficacy and safety of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases - Prospective study of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases
ational Hospital Organization Saitama Hospital0 个研究点目标入组 20 人开始时间: 2016年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) organ metastases excluding bone metastases 2) active concomitant malignancy 3) inflammatory bowel disease (Crohn's disease or ulcerative colitis) 4) use of chemotherapy with myelosuppresion reaction at the same time 5) difficult to participate with the trial, having mentel disorder or psychiatric symptoms 6) immuno-suppression treatment
研究者
相似试验
招募中
不适用
A prospective study to evaluate the efficacy and safety of pregabalin for triweekly abraxane-induced peripheral neuralgiaBreast cancerJPRN-UMIN000006987Kinki University Faculty of Medicine30
招募中
不适用
A prospective study to evaluate the efficacy and safety of a new knife in endoscopic treatment for gastric neoplasmNeoplasmsKCT0005164Asan Medical Center100
尚未招募
不适用
effect of alpha blockers in benign prostatic hyperplasiaCTRI/2021/04/033122DR I C VIGNESH RAJA
招募中
2 期
STUDY TO EVALUATE THE EFFECT AND SAFETY OF AN AYURVEDIC DRUG (URAL CAPSULE) IN RENAL STONESCTRI/2018/07/014706ational Institute of Ayurveda
进行中（未招募）
2 期
A prospective study of investigating the efficacy of FOLFIRI plus Aflibercept as a 2nd line therapy after progression during FOLFOXIRI plus Bevacizumab in unrescetable / metastatic colorectal cancer (CRC) patients.Colorectal CancerJPRN-jRCTs071190003Oki Eiji35